YMRC
MED icon

Yorktown Management & Research Company’s Medifast MED Stock Holding History

Yorktown Management & Research Company’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,900
Closed -$629K – 326
2019
Q2 		$629K Buy
4,900
+418
+9% +$58.1K 0.24% 120
2019
Q1 		$572K Hold
4,482
– – 0.18% 141
2018
Q4 		$560K Buy
4,482
+1,934
+76% +$331K 0.19% 133
2018
Q3 		$565K Buy
+2,548
New +$517K 0.17% 151

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Yorktown Management & Research Company's MED Position: Q3 2019 in Review

Yorktown Management & Research Company sold out of Medifast (MED) in Q3 2019, closing a stake of 4,900 shares — an estimated $629K sold.

Yorktown Management & Research Company first reported a position in MED in Q3 2018 and held it in 4 quarters. The position peaked at $629K in Q2 2019. 239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

  • Yorktown Management & Research Company reported no remaining Medifast position as of Q3 2019 after selling out during the quarter.
  • Yorktown Management & Research Company sold 4,900 Medifast shares in Q3 2019, an estimated $629K.
  • Yorktown Management & Research Company first reported a position in Medifast in Q3 2018 and held it in 4 quarters.
  • Yorktown Management & Research Company's Medifast position peaked at $629K in Q2 2019.
  • 239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on Yorktown Management & Research Company's 13F filing for Q3 2019, filed 1 Nov 2019.